{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:39:34Z","timestamp":1791941974625,"version":"4.3.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T00:00:00Z","timestamp":1407024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s00223-014-9898-8","type":"journal-article","created":{"date-parts":[[2014,8,2]],"date-time":"2014-08-02T07:23:21Z","timestamp":1406964201000},"page":"374-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects on Calcium Homeostasis of Changing PTH Replacement Therapy of Postoperative Hypoparathyroidism from Intact PTH to Teriparatide: A Case Series"],"prefix":"10.1007","volume":"95","author":[{"given":"Lise Sofie","family":"Bislev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Sikjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,3]]},"reference":[{"issue":"10","key":"9898_CR1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","volume":"26","author":"JP Bilezikian","year":"2011","unstructured":"Bilezikian JP, Khan A, Potts JT Jr, Brandi ML, Clarke BL, Shoback D et al (2011) Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res 26(10):2317\u20132337","journal-title":"J Bone Miner Res"},{"issue":"11","key":"9898_CR2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","volume":"28","author":"L Underbjerg","year":"2013","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L (2013) Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res 28(11):2277\u20132285","journal-title":"J Bone Miner Res"},{"issue":"12","key":"9898_CR3","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","volume":"28","author":"J Powers","year":"2013","unstructured":"Powers J, Joy K, Ruscio A, Lagast H (2013) Prevalence and incidence of hypoparathyroidism in the United States using a large claims database. J Bone Miner Res 28(12):2570\u20132576","journal-title":"J Bone Miner Res"},{"issue":"11","key":"9898_CR4","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","volume":"21","author":"MR Rubin","year":"2010","unstructured":"Rubin MR, Sliney J Jr, McMahon DJ, Silverberg SJ, Bilezikian JP (2010) Therapy of hypoparathyroidism with intact parathyroid hormone. Osteoporos Int 21(11):1927\u20131934","journal-title":"Osteoporos Int"},{"issue":"10","key":"9898_CR5","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","volume":"26","author":"T Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L, Hypoparathyroid Study Group (2011) The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J Bone Miner Res 26(10):2358\u20132370","journal-title":"J Bone Miner Res"},{"issue":"9","key":"9898_CR6","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","volume":"88","author":"KK Winer","year":"2003","unstructured":"Winer KK, Ko CW, Reynolds JC, Dowdy K, Keil M, Peterson D et al (2003) Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. J Clin Endocrinol Metab 88(9):4214\u20134220","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"9898_CR7","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","volume":"276","author":"KK Winer","year":"1996","unstructured":"Winer KK, Yanovski JA, Cutler GB Jr (1996) Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. JAMA 276(8):631\u2013636","journal-title":"JAMA"},{"issue":"10","key":"9898_CR8","first-page":"3480","volume":"83","author":"KK Winer","year":"1998","unstructured":"Winer KK, Yanovski JA, Sarani B, Cutler GB Jr (1998) A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. J Clin Endocrinol Metab 83(10):3480\u20133486","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9898_CR9","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.2009-2464","volume":"95","author":"KK Winer","year":"2010","unstructured":"Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB Jr (2010) Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. J Clin Endocrinol Metab 95(6):2680\u20132688","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9898_CR10","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1210\/jc.2011-1908","volume":"97","author":"KK Winer","year":"2012","unstructured":"Winer KK, Zhang B, Shrader JA, Peterson D, Smith M, Albert PS et al (2012) Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. J Clin Endocrinol Metab 97(2):391\u2013399","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9898_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/157488611795684631","volume":"6","author":"T Sikjaer","year":"2011","unstructured":"Sikjaer T, Rejnmark L, Mosekilde L (2011) PTH treatment in hypoparathyroidism. Curr Drug Saf 6(2):89\u201399","journal-title":"Curr Drug Saf"},{"key":"9898_CR12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","volume":"1","author":"M Mannstadt","year":"2013","unstructured":"Mannstadt M, Clarke BL, Vokes T, Brandi ML, Ranganath L, Fraser WD et al (2013) Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. Lancet Diabetes Endocrinol 1:275\u2013283","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"9898_CR13","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/jbmr.1964","volume":"28","author":"T Sikjaer","year":"2013","unstructured":"Sikjaer T, Amstrup AK, Rolighed L, Kjaer SG, Mosekilde L, Rejnmark L (2013) PTH (1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects following 6\u00a0months of treatment. J Bone Miner Res 28(10):2232\u20132243","journal-title":"J Bone Miner Res"},{"issue":"12","key":"9898_CR14","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1359\/jbmr.080803","volume":"23","author":"MR Rubin","year":"2008","unstructured":"Rubin MR, Dempster DW, Zhou H, Shane E, Nickolas T, Sliney J Jr et al (2008) Dynamic and structural properties of the skeleton in hypoparathyroidism. J Bone Miner Res 23(12):2018\u20132024","journal-title":"J Bone Miner Res"},{"issue":"2","key":"9898_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","volume":"18","author":"BL Langdahl","year":"1996","unstructured":"Langdahl BL, Mortensen L, Vesterby A, Eriksen EF, Charles P (1996) Bone histomorphometry in hypoparathyroid patients treated with vitamin D. Bone 18(2):103\u2013108","journal-title":"Bone"},{"issue":"11","key":"9898_CR16","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1002\/jbmr.452","volume":"26","author":"MR Rubin","year":"2011","unstructured":"Rubin MR, Dempster DW, Sliney J Jr, Zhou H, Nickolas TL, Stein EM et al (2011) PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism. J Bone Miner Res 26(11):2727\u20132736","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-014-9898-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-014-9898-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-014-9898-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:41:10Z","timestamp":1558698070000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-014-9898-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,3]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["9898"],"URL":"https:\/\/doi.org\/10.1007\/s00223-014-9898-8","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,3]]}}}